On Target to Outsmart Cancer
Revolution Medicines (revmed.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 80th percentile of 9463 Healthcare brands.
Revolution Medicines is a biopharmaceutical company headquartered in Redwood City, California, founded in 2014. It focuses on discovering, developing, and delivering targeted medicines for patients with RAS-addicted cancers, a group of cancers driven by mutations in the RAS gene family that account for roughly 30 percent of new human cancer diagnoses. The company develops a pipeline of RAS(ON) inhibitors aimed at previously undruggable cancer targets, engaging with the oncology medical community, investors, and research partners in pursuit of new treatment options.
| Brand Name | Revolution Medicines |
|---|---|
| Domain | revmed.com |
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Redwood City |
| Main Competitors | Amgen (90/100), Mirati Therapeutics, Boehringer Ingelheim (76/100), Novartis (71/100), Genentech (84/100), Eli Lilly and Company (78/100), Verastem Oncology (83/100) |
Moz Domain Authority 51/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #285,468 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "At Revolution Medicines our mission is to revolutionize treatment for patients with RAS-addicted cancers through targeted medicines." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, Vue.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Revolution Medicines?", Claude could identify the brand as of September 2026. Revolution Medicines is a clinical-stage biopharmaceutical company focused on developing targeted therapies for RAS-addicted cancers, a class of mutations long considered difficult to drug. Its pipeline includes RAS(ON) inhibitors like daraxonrasib targeting KRAS mutations found Best known for Developing RAS(ON) inhibitor drugs targeting KRAS-mutant cancers, including daraxonrasib.
When asked "Best brands similar to Revolution Medicines?", Claude would recommend Revolution Medicines as of September 2026. It's a notable name in oncology biotech, particularly for its innovative approach to targeting RAS mutations, so it would come up in discussions of companies advancing precision cancer therapies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Revolution Medicines's main competitors in Healthcare: Amgen (90/100), Boehringer Ingelheim (76/100), Novartis (71/100), Genentech (84/100), Eli Lilly and Company (78/100).
Sources: Brand Analyzer scan
Revolution Medicines is a biopharmaceutical company based in Redwood City, California, founded in 2014. It is focused on discovering, developing, and delivering targeted medicines for patients with RAS-addicted cancers.
Sources: Revolution Medicines official site
Revolution Medicines has limited AI-search visibility, scoring 40/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 46, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Revolution Medicines official site
Revolution Medicines was founded in 2014. Revolution Medicines operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Revolution Medicines is headquartered in Redwood City. Revolution Medicines operates in the Healthcare category.
Sources: Wikidata
Revolution Medicines discovers and develops targeted therapeutics, specifically RAS(ON) inhibitors, aimed at treating RAS-addicted cancers-tumors driven by mutations in the RAS gene family that have historically been considered difficult or impossible to target with drugs.
Sources: Revolution Medicines official site
Revolution Medicines scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Revolution Medicines official site
Revolution Medicines is known for its focused pipeline of RAS(ON) inhibitors designed to target RAS-addicted cancers, a class of cancers previously considered undruggable and which represent about 30 percent of new human cancer diagnoses.
Sources: Revolution Medicines official site
Revolution Medicines can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Revolution Medicines official site
Revolution Medicines offers a pipeline of RAS(ON) inhibitors-targeted medicines in development for treating RAS-addicted cancers. These are investigational therapeutics rather than commercially marketed products, aimed at addressing cancer targets previously considered undruggable.
Sources: Revolution Medicines official site
Revolution Medicines' work is intended for patients living with RAS-addicted cancers, and its research and development activities engage the oncology medical community, investors, and research partners interested in cancer therapeutics.
Sources: Revolution Medicines official site
Revolution Medicines scores 40/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Revolution Medicines has a limited AI-visibility profile at 40/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #285,468 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Revolution Medicines from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Revolution Medicines: RevenueWell (82/100), Resilience (82/100), Right at Home (82/100), Ronald McDonald House Charities (RMHC) (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.